HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma

Abstract Background Accompanied by HBV infection, HBV mutations gradually occur because HBV polymerase appears proofread deficiencies. In our previous study, we have identified that EnhII/BCP/PC mutations and genotype C of HBV DNA were associated with hepatocellular carcinoma (HCC) risk. In this stu...

全面介紹

書目詳細資料
Main Authors: Zijun Ge, Ting Tian, Lijuan Meng, Ci Song, Chengxiao Yu, Xin Xu, Jibin Liu, Juncheng Dai, Zhibin Hu
格式: Article
語言:English
出版: Wiley 2019-06-01
叢編:Cancer Medicine
主題:
在線閱讀:https://doi.org/10.1002/cam4.2169
_version_ 1828852974770716672
author Zijun Ge
Ting Tian
Lijuan Meng
Ci Song
Chengxiao Yu
Xin Xu
Jibin Liu
Juncheng Dai
Zhibin Hu
author_facet Zijun Ge
Ting Tian
Lijuan Meng
Ci Song
Chengxiao Yu
Xin Xu
Jibin Liu
Juncheng Dai
Zhibin Hu
author_sort Zijun Ge
collection DOAJ
description Abstract Background Accompanied by HBV infection, HBV mutations gradually occur because HBV polymerase appears proofread deficiencies. In our previous study, we have identified that EnhII/BCP/PC mutations and genotype C of HBV DNA were associated with hepatocellular carcinoma (HCC) risk. In this study, we extend our research to explore HCC prognosis associated genotype and mutations in EnhII/BCP/PC regions. Methods We designed a case‐cohort study of 331 HCC patients to evaluate the effects of the HBV genotypes and mutations on HCC survival. Log‐rank test and Cox proportional hazard models were used for the analyses. Results Results showed that genotype C, which was more frequent in HBV‐related HCC (77.4%), presented a negative signal with HCC survival. Interestingly, we detected a significant association between EnhII/BCP/PC mutation nt1753 and HCC prognosis (Log‐rank P = 0.034). Subgroup analysis revealed that this risk effect was more pronounced in non‐B genotype (P = 0.090 for heterogeneity test). We also detected a borderline multiplicative interaction between genotypes of nt1753 and HBV genotype on HCC survival (P for interaction = 0.069). Conclusions These findings indicated that, in Chinese population, nt1753 in EnhII/BCP/PC region might be a novel marker for HCC prognosis.
first_indexed 2024-12-13T00:04:36Z
format Article
id doaj.art-b3f1366bb2d44bbd92f4ab199d25e06c
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-12-13T00:04:36Z
publishDate 2019-06-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-b3f1366bb2d44bbd92f4ab199d25e06c2022-12-22T00:06:18ZengWileyCancer Medicine2045-76342019-06-01863086309310.1002/cam4.2169HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinomaZijun Ge0Ting Tian1Lijuan Meng2Ci Song3Chengxiao Yu4Xin Xu5Jibin Liu6Juncheng Dai7Zhibin Hu8State Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaIntegrated Hospital of Traditional Chinese Medicine Southern Medical University Guangzhou ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaDepartment of Hepatobiliary Surgery Nantong Tumor Hospital Nantong ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Nanjing Medical University Nanjing ChinaAbstract Background Accompanied by HBV infection, HBV mutations gradually occur because HBV polymerase appears proofread deficiencies. In our previous study, we have identified that EnhII/BCP/PC mutations and genotype C of HBV DNA were associated with hepatocellular carcinoma (HCC) risk. In this study, we extend our research to explore HCC prognosis associated genotype and mutations in EnhII/BCP/PC regions. Methods We designed a case‐cohort study of 331 HCC patients to evaluate the effects of the HBV genotypes and mutations on HCC survival. Log‐rank test and Cox proportional hazard models were used for the analyses. Results Results showed that genotype C, which was more frequent in HBV‐related HCC (77.4%), presented a negative signal with HCC survival. Interestingly, we detected a significant association between EnhII/BCP/PC mutation nt1753 and HCC prognosis (Log‐rank P = 0.034). Subgroup analysis revealed that this risk effect was more pronounced in non‐B genotype (P = 0.090 for heterogeneity test). We also detected a borderline multiplicative interaction between genotypes of nt1753 and HBV genotype on HCC survival (P for interaction = 0.069). Conclusions These findings indicated that, in Chinese population, nt1753 in EnhII/BCP/PC region might be a novel marker for HCC prognosis.https://doi.org/10.1002/cam4.2169HBV genotypeHBV mutationHCC
spellingShingle Zijun Ge
Ting Tian
Lijuan Meng
Ci Song
Chengxiao Yu
Xin Xu
Jibin Liu
Juncheng Dai
Zhibin Hu
HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
Cancer Medicine
HBV genotype
HBV mutation
HCC
title HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
title_full HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
title_fullStr HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
title_full_unstemmed HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
title_short HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
title_sort hbv mutations in enhii bcp pc region contribute to the prognosis of hepatocellular carcinoma
topic HBV genotype
HBV mutation
HCC
url https://doi.org/10.1002/cam4.2169
work_keys_str_mv AT zijunge hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT tingtian hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT lijuanmeng hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT cisong hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT chengxiaoyu hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT xinxu hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT jibinliu hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT junchengdai hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma
AT zhibinhu hbvmutationsinenhiibcppcregioncontributetotheprognosisofhepatocellularcarcinoma